Neuroendocrine Tumors Cancer from Diagnosis to Treatment


What Are Neuroendocrine Tumors?

Neuroendocrine Tumors are rare types of cancers that develop from neuroendocrine cells - specialized cells that have traits of both nerve cells and hormone-producing | endocrine | cells.

These cells are found throughout the body, especially in the lungs, pancreas, and gastrointestinal tract.

NETs can be benign | slow-growing or malignant | cancerous and aggressive, and they may produce hormones that cause specific symptoms depending on where they occur.


Types of Neuroendocrine Tumors

Gastrointestinal
Found in the stomach, intestines, appendix, colon, or rectum.
May cause hormone-related symptoms like flushing and diarrhea.

Pancreatic
Arise in the pancreas.
Examples ➧ insulinoma, gastrinoma, glucagonoma, VIPoma, and somatostatinoma.

Pulmonary
Develop in the lungs or bronchial tubes.
Can be typical or atypical carcinoid tumors.

Other Rare NETs
Found in adrenal glands | pheochromocytoma, thyroid | medullary carcinoma, or reproductive organs.


1. Signs and Symptoms

Functional NETs | Hormone-Secreting:
Flushing or redness of the skin
Severe diarrhea
Wheezing or shortness of breath
Rapid heartbeat
Low blood sugar in insulin-secreting tumors | hypoglycemia
Abdominal pain or cramping
Unexplained weight loss

Non-Functional NETs | Non-Secreting:
Abdominal pain or bloating
Mass or lump in the abdomen
Nausea, vomiting, or bowel obstruction
Fatigue and weakness


2. Causes and Risk Factors

Family history of endocrine syndromes
Smoking
Long-term stomach inflammation


3. Diagnostic Procedure

Medical History & Physical Exam
Review of symptoms, hormone-related signs, and family history.

Blood and Urine Tests
Detect excess hormones or biochemical markers

Imaging Tests
CT Scan / MRI:
Shows tumor size and spread.

PET Scan:
Detects neuroendocrine cells with high sensitivity.

Octreotide Scan:
Identifies somatostatin receptor-positive NETs.

Endoscopy or Colonoscopy
Used to visualize and biopsy GI tract NETs.

Biopsy
Confirms diagnosis and determines tumor grade based on cell growth rate.


4. Staging and Grading

NETs are staged like other cancers based on tumor size and spread.
They are also graded by how fast the cells grow.

G1 - Well-differentiated, slow-growing - <3%
G2 - Moderately differentiated - 3-20%
G3 - Poorly differentiated, aggressive - >20%


5. Treatment Options

Surgery

Primary treatment for localized NETs.
May involve removal of tumor and nearby lymph nodes.
In metastatic cases, debulking surgery reduces symptoms.

Somatostatin Analogs

Octreotide and Lanreotide control hormone-related symptoms and slow tumor growth.

Targeted Therapy

Everolimus and Sunitinib block specific cancer growth pathways.
Effective in advanced pancreatic NETs.

Peptide Receptor Radionuclide Therapy

A new treatment using radioactive isotopes attached to somatostatin analogs.
Delivers radiation directly to cancer cells.

Chemotherapy

Used mainly for high-grade or rapidly growing NETs.
Common drugs:
Streptozocin, Temozolomide, Capecitabine, Etoposide.

Immunotherapy

Still under research; early studies show promise for advanced disease.

Symptom Control

Medications to relieve diarrhea, flushing, or pain.
Interferon-alpha may help reduce hormone secretion in some cases.


6. Preferred Nutrition for Patients

Protein-rich foods:
eggs, fish, chicken, legumes.

Fruits & vegetables:
leafy greens and berries

Whole grains:
oats, quinoa, brown rice.

Healthy fats:
olive oil, nuts, avocado.

Hydration:
water, herbal teas, clear soups.

Small, frequent meals
to reduce discomfort.


7. Follow-Up and Monitoring

Regular blood hormone tests and imaging scans to monitor recurrence.

Emotional and nutritional support improves quality of life.